2014
“Inflammation and arterial stiffness in humans”
Jain S, Khera R, Corrales–Medina V, Townsend RR, Chirinos JA. “Inflammation and arterial stiffness in humans”. Atherosclerosis 2014, 237: 381-390. PMID: 25463062, DOI: 10.1016/j.atherosclerosis.2014.09.011.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPrimary inflammatory diseaseArterial stiffnessArterial stiffeningInflammatory diseasesPrimary inflammatory conditionsAnti-inflammatory interventionsRole of inflammationAnti-inflammatory therapyEffect of statinsEffects of inflammationPotential therapeutic targetCardiovascular morbiditySubclinical inflammationInflammatory conditionsGeneral populationTherapeutic targetInflammationEstablished markerNormal adultsPotential mechanismsDiseaseHypertensionMorbidityStatinsArtery
2012
Membrane-Bound Complement Regulatory Proteins as Biomarkers and Potential Therapeutic Targets for SLE
Das N, Biswas B, Khera R. Membrane-Bound Complement Regulatory Proteins as Biomarkers and Potential Therapeutic Targets for SLE. Advances In Experimental Medicine And Biology 2012, 735: 55-81. PMID: 23402019, DOI: 10.1007/978-1-4614-4118-2_4.ChaptersConceptsComplement regulatory proteinsMembrane-bound complement regulatory proteinsTherapeutic targetDisease activityAutoimmune disordersAmerican Rheumatology AssociationAntidouble-stranded DNADisease activity markersSLE disease activitySystemic autoimmune disorderSystemic lupus erythematosusPotential therapeutic targetGene knockout miceLevels of DAFAntinuclear antibodiesLupus erythematosusMultiorgan involvementRheumatology AssociationInflammatory disordersReproductive ageActivity markersNoninvasive biomarkersDiagnostic criteriaKnockout miceSLE
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply